Advertisement
The risk of osteonecrosis of the jaw is highest in association with intravenous bisphosphonate use

Osteonecrosis of Jaw Risk Highest for IV Bisphosphonate Use

0
High risk for zoledronate, denosumab mainly in prevention of skeletal-related events
Use of dipeptidyl peptidase-4 inhibitors in type 2 diabetes is tied to severe joint pain in some patients

FDA Warns of Joint Pain Tied to DPP-4 Inhibitors

0
Agency advises users with such symptoms to contact their doctor
Azithromycin is routinely prescribed to hospitalized patients despite risk factors for corrected QT prolongation and administration of interacting medications

Azithromycin Routine in Hospital Despite Risk for QTc Prolongation

0
Providers not considering risk of QTc-prolonging meds accumulation, authors say
The outcome of a recent case regarding the termination of physicians by an insurance company following a dispute over the necessity of medical services provided has serious implications for physicians and their patients

AMA: Ruling Makes It Easier for Insurers to Terminate Doctors

0
Court supported insurance company in termination of doctors after dispute over necessity of services
Older women with osteoporosis may benefit from a few years on growth hormone

Growth Hormone May Benefit Bone Health in Older Women

0
But researcher says high cost, need to get shots in clinics make it an unlikely osteoporosis treatment
Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration

FDA Approves Repatha for Certain Patients With High Cholesterol

0
Approved for patients unable to get LDL cholesterol under control with current treatment options
Many elderly oncology patients use complementary and alternative medications

Many Elderly Oncology Patients Taking Alternative Medicines

0
Associated with polypharmacy, vision impairment, and urologic comorbidities
For most atrial fibrillation patients taking warfarin who require temporary interruption for a procedure

Periop Bridging Unnecessary for Most A-Fib Patients on Warfarin

0
Arterial thromboembolism risk doesn't appear to rise without additional drug treatment
Discontinuing antihypertensive treatment in seniors with mild cognitive deficits does not improve mental functioning

No Cognitive Benefits Seen for Elderly Who Stop HTN Rx

0
Prior research suggests lower BP increases risk for cognitive decline in elderly
Too few members of certain minority groups are pursuing careers in U.S. medicine

Too Few Blacks, Hispanics Pursuing Careers As Physicians

0
Shortage of minority physicians may affect U.S. patient care, experts say